PLEASANTON, Calif., April 21, 2015 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (Nasdaq:BABY) announced today that it has received FDA 510(k) clearance for the Quantum amplifier; an innovative high channel count amplifier that has applications in epilepsy and seizure monitoring along with research applications.
Quantum is the first amplifier in the market to offer up to 256 channels in a compact, wearable package. Quantum is also the first compact amplifier to feature up to 16 kHz sampling rates providing increased visibility of faster brain frequencies combined with a software controlled Digital Switch Matrix facilitating functional brain mapping through cortical stimulation and a dual data stream for an efficient clinical and research workflow. The Quantum amplifier combined with Natus Neuroworks software produce an enhanced user experience resulting in improved patient care.
The Quantum amplifier compliments our market leading neurodiagnostic product line in use today by epilepsy centers, EEG labs, sleep disorder centers, emergency rooms and intensive care units worldwide.
"Natus is committed to working with healthcare providers and leading academic institutions to develop breakthrough solutions and improve patient care. This new product is a quantum leap in amplifier technology and is a great example of our commitment," said Jim Hawkins, CEO and President of Natus Medical Incorporated.
Quantum will be featured at the Natus Neurology booth at the American Academy of Neurology (AAN) and at the American Epilepsy Society (AES) meetings as well as other leading US & International trade shows throughout the year.
About Natus Medical
Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in neurological dysfunction, newborn care and hearing impairment.
Additional information about Natus Medical can be found at www.natus.com.
CONTACT: Company Contact: Natus Medical Incorporated Jonathan A. Kennedy Sr. Vice President Finance and Chief Financial Officer (925) 223-6700 InvestorRelations@Natus.com
Source:Natus Medical Incorporated